BAY-876
BAY-876 is a potent and selective oral inhibitor of the glucose transporter GLUT1 (IC50=2 nM), showing over 100-fold selectivity versus GLUT2/3/4. It suppresses glycolytic metabolism and demonstrates antitumor activity in both cellular assays and in vivo models, making it a valuable tool for cancer metabolism research.
Product Specifications
CAS Number
1799753-84-6
Product Name Alternative
4-N-[1-[ (4-Cyanophenyl) methyl]-5-methyl-3- (trifluoromethyl) pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide
Field of Research
Cell Biology, Immunology & Inflammation
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (up to at least 25 mg/ml)
Smiles
Cc1c (NC (=O) c2cc (nc3cc (F) ccc23) C (N) =O) c (nn1Cc1ccc (cc1) C#N) C (F) (F) F
Molecular Formula
C24H16F4N6O2
Molecular Weight
496.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N4-[1- (4-Cyanobenzyl) -5-methyl-3- (trifluoromethyl) -1H-pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
FITC-Linked Polyclonal Antibody to Beta-2-Microglobulin (b2M)
FITC-Linked Polyclonal Antibody to Beta-2-Microglobulin (b2M)
FITC-Linked Polyclonal Antibody to Beta-2-Microglobulin (b2M)
FITC-Linked Polyclonal Antibody to Beta-2-Microglobulin (b2M)